By BMI has had a rough few years in the public conversation. What used to be a standard tool in every doctor’s office has become a flashpoint – criticized as racist, sexist, outdated, and meaningless. The backlash has been loud enough that some people now dismiss it entirely, while others defend it just as fiercely. Both camps are missing something.
The truth about BMI sits in messier territory than either side typically admits. It’s a flawed tool that’s been misused for decades – and it’s also a screening metric with genuine epidemiological value that shouldn’t be thrown out entirely. Understanding both sides of that is actually useful, which is what this article is for.
What BMI is and where it came from
BMI – Body Mass Index – is calculated by dividing your weight in kilograms by the square of your height in meters (kg/m²). In the US, where pounds and inches are standard, the formula uses a conversion factor. The result is a single number that places you into one of four categories according to the CDC and World Health Organization:
| BMI range | Category |
|---|---|
| Below 18.5 | Underweight |
| 18.5 – 24.9 | Normal weight |
| 25.0 – 29.9 | Overweight |
| 30.0 and above | Obese |
The formula was developed in the 1830s by a Belgian mathematician named Adolphe Quetelet – not a physician, notably – as a way to describe the statistical distribution of body weight across populations. He was interested in defining the “average man,” not in assessing individual health.
BMI wasn’t widely adopted as a clinical health metric until the 1970s and 1980s, when large epidemiological studies found correlations between higher BMI and increased risk of cardiovascular disease, type 2 diabetes, and other chronic conditions. The CDC formally adopted the current cutoff thresholds in 1998. In a single day, millions of Americans who were previously classified as “normal weight” became “overweight” – not because anything changed about them, but because a committee moved a line.
That history matters because it reveals something important: BMI cutoffs are statistical and somewhat arbitrary constructs, not biologically precise thresholds. The line between “normal” and “overweight” doesn’t mark the point at which health risk suddenly changes. It marks a point chosen for administrative convenience.
The real problems with BMI – and they’re significant
BMI’s critics aren’t wrong. There are genuine, well-documented limitations to using BMI as a health metric – especially at the individual level.
It can’t distinguish fat from muscle. This is the most commonly cited problem, and it’s real. BMI is a measure of mass relative to height – it has no way of knowing what that mass is made of. A highly muscular athlete and a sedentary person with high body fat can have identical BMIs and radically different health profiles. According to one widely cited study published in the International Journal of Obesity, roughly 30% of people classified as “normal weight” by BMI had metabolic risk factors consistent with obesity when measured by body fat percentage – while 50% of people in the “overweight” BMI range were metabolically healthy. Those are enormous misclassification rates if BMI is being used to make individual health judgments.
It ignores fat distribution entirely. Where fat is stored matters as much as how much of it there is. Visceral fat – stored around abdominal organs – is metabolically active and drives inflammation, insulin resistance, and cardiovascular risk. Subcutaneous fat – stored under the skin – is relatively inert. Two people with the same BMI can have completely different distributions of visceral versus subcutaneous fat, and therefore very different actual risk profiles. BMI captures none of this.
It performs differently across ethnic groups. The current BMI thresholds were developed primarily from data on white European populations. Research has consistently shown that people of South Asian, East Asian, and other backgrounds carry greater metabolic risk at lower BMI values than the current categories suggest. The CDC and WHO acknowledge this – some countries have adopted lower BMI thresholds for Asian populations – but most American clinical practice still uses the original cutoffs. This means BMI systematically underestimates risk for a significant portion of the US population.
It says nothing about fitness, lifestyle, or metabolic health. A person who smokes, is sedentary, sleeps five hours, and eats mostly ultra-processed food might have a BMI of 23. A person who exercises regularly, sleeps eight hours, eats a varied whole-food diet, and has excellent blood markers might have a BMI of 28. BMI ranks the first person as “healthier” by its single metric. That’s a significant limitation for a tool used to make clinical recommendations.
“BMI was designed to describe populations, not diagnose individuals. Using it to make personal health judgments is a bit like using the average rainfall in your city to decide whether to bring an umbrella today – statistically interesting, individually insufficient.”
What BMI actually does well
Here’s where the “BMI is completely useless” argument goes wrong: when used as a population-level screening tool at scale, BMI does correlate meaningfully with health risk – and that correlation has held up across enormous datasets.
At the population level, higher BMI is consistently associated with elevated risk of type 2 diabetes, cardiovascular disease, hypertension, certain cancers, sleep apnea, osteoarthritis, and all-cause mortality. These relationships aren’t perfect – they’re associations, not causes, and they don’t apply identically to every individual – but they’re real and they’re consistent enough to be clinically useful in the aggregate.
This is why public health agencies, insurance companies, and epidemiologists continue to use BMI. For tracking obesity trends across populations, comparing risk across groups, or identifying individuals who may benefit from further metabolic evaluation, it performs adequately well precisely because it’s cheap, non-invasive, and universally calculable from two measurements anyone can take.
The error isn’t that BMI exists. The error is using a population-level tool as though it were an individual diagnostic instrument – which is not what it was designed for.
Better tools – and why they’re not replacing BMI yet
Several measures provide more clinically meaningful information about individual metabolic risk than BMI alone.
Waist circumference is the most practically useful addition to BMI in routine clinical assessment. It’s a direct proxy for central adiposity – abdominal fat accumulation – which is more strongly associated with metabolic risk than overall body weight. The American Heart Association considers waist circumference above 35 inches (88cm) in women and above 40 inches (102cm) in men to be a significant cardiovascular risk marker, independent of BMI.
Waist-to-height ratio has emerged from research as an even better predictor of cardiometabolic risk than either BMI or waist circumference alone. A ratio below 0.5 – meaning your waist circumference is less than half your height – is associated with significantly lower metabolic risk across most populations and ethnic groups. It’s simple to calculate and accounts for height in a way that raw waist circumference doesn’t.
Body fat percentage measured through DEXA scanning (the gold standard), hydrostatic weighing, or reasonably accurate bioelectrical impedance gives a direct picture of body composition that BMI cannot. The limitation is cost and accessibility – DEXA scans aren’t standard in most clinical practices and aren’t typically covered by insurance for routine screening.
Metabolic blood markers – fasting glucose, HbA1c, fasting insulin, triglycerides, HDL cholesterol, blood pressure – tell you directly what’s happening at the level of actual metabolic function. A person with a BMI of 27 and normal blood glucose, normal blood pressure, normal lipids, and no insulin resistance has a very different risk profile than someone with the same BMI and multiple abnormal markers.
| Metric | What it measures | Limitations |
|---|---|---|
| BMI | Weight relative to height | Can’t distinguish fat from muscle; ignores fat distribution; varies by ethnicity |
| Waist circumference | Central adiposity | Doesn’t account for height; cutoffs less accurate across ethnicities |
| Waist-to-height ratio | Central fat relative to frame size | Less familiar to patients and clinicians; not universally standardized |
| Body fat % (DEXA) | Actual fat and lean mass | Expensive; not widely available for routine screening |
| Metabolic blood markers | Direct metabolic function | Requires blood draw; doesn’t directly measure body composition |
The reason BMI persists despite its limitations isn’t stubbornness. It’s practicality. A tape measure and a scale are available in every clinical setting on earth. DEXA machines and metabolic panels are not.
What this means for your next doctor’s visit
If your doctor references your BMI, it’s worth understanding what they’re actually using it for. In most clinical contexts, a BMI in the overweight or obese range is being used as a prompt to look further – to check blood pressure, order metabolic bloodwork, discuss lifestyle factors – not as a verdict on your health status by itself.
If your BMI is elevated but your metabolic markers are normal, you’re physically active, and you feel well – that’s important clinical information too, and you’re entitled to that fuller conversation. Asking “what does my BMI mean in the context of my bloodwork and activity level?” is a completely reasonable question to bring to any appointment.
Conversely, if your BMI is in the “normal” range but you have a large waist circumference, abnormal blood sugar, high triglycerides, or low HDL – that combination warrants attention regardless of what the BMI says. Metabolically unhealthy normal-weight individuals – sometimes called “TOFI” (thin outside, fat inside) – face genuine cardiovascular risk that BMI alone misses.
“A normal BMI is not a clean bill of health. An elevated BMI is not a diagnosis. Both statements are equally true, and both matter for how we use this number responsibly.”
FAQs
My BMI says I’m overweight but I exercise regularly and my bloodwork is fine. Should I be worried? BMI alone isn’t sufficient to assess your health risk. If your blood pressure, blood glucose, HbA1c, lipid panel, and waist circumference are all within healthy ranges, and you’re physically active with good cardiorespiratory fitness, your metabolic risk profile is likely favorable despite the BMI classification. This is the “metabolically healthy overweight” phenotype – it exists, it’s common among muscular and physically active people, and it’s precisely why BMI shouldn’t be used in isolation. Discuss the full picture with your doctor rather than focusing on the single number.
Are the BMI cutoffs different for different ethnicities? The evidence suggests they should be, but most US clinical practice still uses the same thresholds for everyone. Research consistently shows that South Asian and East Asian populations carry higher metabolic risk at lower BMI values than the current “overweight” cutoff of 25. The WHO has acknowledged this with suggested lower thresholds for Asian populations. If you’re of South Asian or East Asian descent, your doctor may want to monitor metabolic markers even in BMI ranges typically considered “normal.”
Is waist circumference a better measurement than BMI? For individual metabolic risk assessment, waist circumference and waist-to-height ratio are generally more informative than BMI because they capture central adiposity – the visceral fat that drives metabolic risk – rather than just overall mass. At the population level, BMI performs adequately. In clinical practice, the two are best used together. A BMI above 25 with a waist circumference above 35 inches (women) or 40 inches (men) represents a more meaningful signal than either measure alone.
Can someone have a “healthy” BMI and still be unhealthy? Yes – and this is an important point that the BMI debate often misses. Normal-weight metabolic obesity – having a BMI in the normal range with significant visceral fat and metabolic dysfunction – is a real phenomenon. People in this category may have normal or near-normal weight but carry excess abdominal fat, insulin resistance, high triglycerides, and elevated cardiovascular risk. BMI misses them entirely, which is why waist circumference and metabolic markers matter regardless of what the scale says.
Should BMI be abandoned entirely? Probably not – but it needs to be repositioned. As a population-level epidemiological tool for tracking trends and flagging individuals for further evaluation, it retains value. As a standalone individual health verdict, it’s inadequate. The most reasonable position is using BMI as one screening data point that prompts broader assessment, rather than either treating it as a definitive health measure or dismissing it as meaningless.
Disclaimer
This article is for educational purposes only and does not constitute medical advice. BMI is one of many factors considered in clinical health assessment and should always be interpreted alongside other measurements and in the context of your personal health history. If you have concerns about your weight, body composition, or metabolic health, please consult a qualified healthcare provider for individualized evaluation.
References
- Flegal KM, et al. (2005). Excess deaths associated with underweight, overweight, and obesity. JAMA, 293(15), 1861-1867. https://doi.org/10.1001/jama.293.15.1861
- Tomiyama AJ, et al. (2016). Misclassification of cardiometabolic health when using body mass index categories in NHANES 2005-2012. International Journal of Obesity, 40(5), 883-886. https://doi.org/10.1038/ijo.2016.17
- Pischon T, et al. (2008). General and abdominal adiposity and risk of death in Europe. New England Journal of Medicine, 359(20), 2105-2120. https://doi.org/10.1056/NEJMoa0801891
- WHO Expert Consultation. (2004). Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. The Lancet, 363(9403), 157-163. https://doi.org/10.1016/S0140-6736(03)15268-3
- Centers for Disease Control and Prevention. (2024). About adult BMI. https://www.cdc.gov/healthyweight/assessing/bmi/adult_bmi/index.html
- American Heart Association. (2023). Waist circumference and cardiometabolic risk. https://www.heart.org
- Ashwell M, Gunn P, Gibson S. (2012). Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors. Obesity Reviews, 13(3), 275-286. https://doi.org/10.1111/j.1467-789X.2011.00952.x
- Ortega FB, Lavie CJ, Blair SN. (2016). Obesity and cardiovascular disease. Circulation Research, 118(11), 1752-1770. https://doi.org/10.1161/CIRCRESAHA.115.306883
